Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)

[...]of these resistance patterns, the World Health Organization recently highlighted the need for new antimicrobials to treat fluoroquinolone-resistant Campylobacter and Shigella [6]. If AMR bacteria become more common in NHPs, potential spillover events may occur to humans leading to both serious...

Full description

Saved in:
Bibliographic Details
Published in:PLoS pathogens 2022-09, Vol.18 (9), p.e1010831-e1010831
Main Authors: Bohm, Rudolf P, Breed, Matthew W, Cohen, Joyce K, Haertel, Andrew J, Halliday, Lisa C, Kramer, Joshua A, Lieberman, Mia T, Rice, Kelly A, Roberts, Jeffery A, Russell-Logrigue, Kasi E, Salyards, Gregory W, Scorpio, Diana G, Weese, J Scott
Format: Article
Language:English
Subjects:
Animals
Anti-infective agents
Antiinfectives and antibacterials
Antimicrobial agents
Bacteria
Biology and Life Sciences
Campylobacter
Combined Modality Therapy
Complications and side effects
Dosage and administration
Drug resistance
Drug resistance in microorganisms
Drug therapy
Formal Comment
Gastrointestinal diseases
Health care
Inflammation
Macaca mulatta
Medicine and Health Sciences
Mitigation
Pandemics
Pathogens
Public health
Reproducibility
Risk factors
Shigella
Simian Acquired Immunodeficiency Syndrome
Simian Immunodeficiency Virus
Staphylococcus infections
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c610t-7e31171422262cf8078b8117d0b89b201d88391aed67f2dcd7346e8f4044696d3
container_end_page e1010831
container_issue 9
container_start_page e1010831
container_title PLoS pathogens
container_volume 18
creator Bohm, Rudolf P
Breed, Matthew W
Cohen, Joyce K
Haertel, Andrew J
Halliday, Lisa C
Kramer, Joshua A
Lieberman, Mia T
Rice, Kelly A
Roberts, Jeffery A
Russell-Logrigue, Kasi E
Salyards, Gregory W
Scorpio, Diana G
Weese, J Scott
description [...]of these resistance patterns, the World Health Organization recently highlighted the need for new antimicrobials to treat fluoroquinolone-resistant Campylobacter and Shigella [6]. If AMR bacteria become more common in NHPs, potential spillover events may occur to humans leading to both serious public health consequences and erosion of public trust in our research endeavors. The authors did not monitor any bacterial resistance patterns before or after the treatment or report antimicrobial susceptibility of common bacteria identified within the colony. [...]if this approach is used, it must be reported in the literature in the methods section of papers to promote research reproducibility.
doi_str_mv 10.1371/journal.ppat.1010831
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2725275858</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A720576072</galeid><doaj_id>oai_doaj_org_article_46fe04ed2faa43e7b1b13a1683b75b69</doaj_id><sourcerecordid>A720576072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-7e31171422262cf8078b8117d0b89b201d88391aed67f2dcd7346e8f4044696d3</originalsourceid><addsrcrecordid>eNqVU01v1DAQjRCIlsI_QGCVS3vYxV-xsxeksqJlpQISBa6WE0-yXiXx1nYq-jv5Qzi726qLekE-ZDR5857neSbLXhM8JUyS9ys3-F630_VaxynBBBeMPMkOSZ6ziWSSP30QH2QvQlhhzAkj4nl2wAQRgvPZYfbn3PlOt2juug76iFyPjr_YaBsdbYpdjaA30NkKXSwm0esqoqS3dA30kw6M1REMsn3d6q7blsSld0OzRAZuoHXrLWuNuqGNtnMmaUUPOm7yHhqbAqT7RBIDst16VEgsV4tfSFfXgw12w2p75JcQhoA6XenrAcIxKm_RR1cttY8IIkpWoBOKKTl9mT2rdRvg1e57lP08__Rj_nly-e1iMT-7nFSC4DiRwAiRhFNKBa3qAsuiLFLG4LKYlRQTUxRsRjQYIWtqKiMZF1DUHHMuZsKwo-ztlnfduqB27xEUlTSnMi_yIiEWW4RxeqXW3nba3yqnrdoknG9Uur2tWlBc1IA5GFprzRnIkpSEaSIKVsq8FLPE9WGnNpTJ-Sr553W7R7r_p7dL1bgbNcsJF5gmgpMdgXejgVF1NlTQtroHN4z3JoVgHFORoO_-gT7e3Q7V6NRAGgI3DshIqs4kxbkUWI6y00dQ6WzGyvVQ25TfKzjdK0iYCL9jo4cQ1OLq-39gv-5j-RZbeReCh_reO4LVuFJ3TapxpdRupVLZm4e-3xfd7RD7C2pLHhM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2725275858</pqid></control><display><type>article</type><title>Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Bohm, Rudolf P ; Breed, Matthew W ; Cohen, Joyce K ; Haertel, Andrew J ; Halliday, Lisa C ; Kramer, Joshua A ; Lieberman, Mia T ; Rice, Kelly A ; Roberts, Jeffery A ; Russell-Logrigue, Kasi E ; Salyards, Gregory W ; Scorpio, Diana G ; Weese, J Scott</creator><contributor>Klatt, Nichole R.</contributor><creatorcontrib>Bohm, Rudolf P ; Breed, Matthew W ; Cohen, Joyce K ; Haertel, Andrew J ; Halliday, Lisa C ; Kramer, Joshua A ; Lieberman, Mia T ; Rice, Kelly A ; Roberts, Jeffery A ; Russell-Logrigue, Kasi E ; Salyards, Gregory W ; Scorpio, Diana G ; Weese, J Scott ; Klatt, Nichole R.</creatorcontrib><description>[...]of these resistance patterns, the World Health Organization recently highlighted the need for new antimicrobials to treat fluoroquinolone-resistant Campylobacter and Shigella [6]. If AMR bacteria become more common in NHPs, potential spillover events may occur to humans leading to both serious public health consequences and erosion of public trust in our research endeavors. The authors did not monitor any bacterial resistance patterns before or after the treatment or report antimicrobial susceptibility of common bacteria identified within the colony. [...]if this approach is used, it must be reported in the literature in the methods section of papers to promote research reproducibility.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1010831</identifier><identifier>PMID: 36166449</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Anti-infective agents ; Antiinfectives and antibacterials ; Antimicrobial agents ; Bacteria ; Biology and Life Sciences ; Campylobacter ; Combined Modality Therapy ; Complications and side effects ; Dosage and administration ; Drug resistance ; Drug resistance in microorganisms ; Drug therapy ; Formal Comment ; Gastrointestinal diseases ; Health care ; Inflammation ; Macaca mulatta ; Medicine and Health Sciences ; Mitigation ; Pandemics ; Pathogens ; Public health ; Reproducibility ; Risk factors ; Shigella ; Simian Acquired Immunodeficiency Syndrome ; Simian Immunodeficiency Virus ; Staphylococcus infections</subject><ispartof>PLoS pathogens, 2022-09, Vol.18 (9), p.e1010831-e1010831</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c610t-7e31171422262cf8078b8117d0b89b201d88391aed67f2dcd7346e8f4044696d3</cites><orcidid>0000-0002-2286-1106</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2725275858?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2725275858?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36166449$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Klatt, Nichole R.</contributor><creatorcontrib>Bohm, Rudolf P</creatorcontrib><creatorcontrib>Breed, Matthew W</creatorcontrib><creatorcontrib>Cohen, Joyce K</creatorcontrib><creatorcontrib>Haertel, Andrew J</creatorcontrib><creatorcontrib>Halliday, Lisa C</creatorcontrib><creatorcontrib>Kramer, Joshua A</creatorcontrib><creatorcontrib>Lieberman, Mia T</creatorcontrib><creatorcontrib>Rice, Kelly A</creatorcontrib><creatorcontrib>Roberts, Jeffery A</creatorcontrib><creatorcontrib>Russell-Logrigue, Kasi E</creatorcontrib><creatorcontrib>Salyards, Gregory W</creatorcontrib><creatorcontrib>Scorpio, Diana G</creatorcontrib><creatorcontrib>Weese, J Scott</creatorcontrib><title>Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>[...]of these resistance patterns, the World Health Organization recently highlighted the need for new antimicrobials to treat fluoroquinolone-resistant Campylobacter and Shigella [6]. If AMR bacteria become more common in NHPs, potential spillover events may occur to humans leading to both serious public health consequences and erosion of public trust in our research endeavors. The authors did not monitor any bacterial resistance patterns before or after the treatment or report antimicrobial susceptibility of common bacteria identified within the colony. [...]if this approach is used, it must be reported in the literature in the methods section of papers to promote research reproducibility.</description><subject>Animals</subject><subject>Anti-infective agents</subject><subject>Antiinfectives and antibacterials</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Biology and Life Sciences</subject><subject>Campylobacter</subject><subject>Combined Modality Therapy</subject><subject>Complications and side effects</subject><subject>Dosage and administration</subject><subject>Drug resistance</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Formal Comment</subject><subject>Gastrointestinal diseases</subject><subject>Health care</subject><subject>Inflammation</subject><subject>Macaca mulatta</subject><subject>Medicine and Health Sciences</subject><subject>Mitigation</subject><subject>Pandemics</subject><subject>Pathogens</subject><subject>Public health</subject><subject>Reproducibility</subject><subject>Risk factors</subject><subject>Shigella</subject><subject>Simian Acquired Immunodeficiency Syndrome</subject><subject>Simian Immunodeficiency Virus</subject><subject>Staphylococcus infections</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqVU01v1DAQjRCIlsI_QGCVS3vYxV-xsxeksqJlpQISBa6WE0-yXiXx1nYq-jv5Qzi726qLekE-ZDR5857neSbLXhM8JUyS9ys3-F630_VaxynBBBeMPMkOSZ6ziWSSP30QH2QvQlhhzAkj4nl2wAQRgvPZYfbn3PlOt2juug76iFyPjr_YaBsdbYpdjaA30NkKXSwm0esqoqS3dA30kw6M1REMsn3d6q7blsSld0OzRAZuoHXrLWuNuqGNtnMmaUUPOm7yHhqbAqT7RBIDst16VEgsV4tfSFfXgw12w2p75JcQhoA6XenrAcIxKm_RR1cttY8IIkpWoBOKKTl9mT2rdRvg1e57lP08__Rj_nly-e1iMT-7nFSC4DiRwAiRhFNKBa3qAsuiLFLG4LKYlRQTUxRsRjQYIWtqKiMZF1DUHHMuZsKwo-ztlnfduqB27xEUlTSnMi_yIiEWW4RxeqXW3nba3yqnrdoknG9Uur2tWlBc1IA5GFprzRnIkpSEaSIKVsq8FLPE9WGnNpTJ-Sr553W7R7r_p7dL1bgbNcsJF5gmgpMdgXejgVF1NlTQtroHN4z3JoVgHFORoO_-gT7e3Q7V6NRAGgI3DshIqs4kxbkUWI6y00dQ6WzGyvVQ25TfKzjdK0iYCL9jo4cQ1OLq-39gv-5j-RZbeReCh_reO4LVuFJ3TapxpdRupVLZm4e-3xfd7RD7C2pLHhM</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Bohm, Rudolf P</creator><creator>Breed, Matthew W</creator><creator>Cohen, Joyce K</creator><creator>Haertel, Andrew J</creator><creator>Halliday, Lisa C</creator><creator>Kramer, Joshua A</creator><creator>Lieberman, Mia T</creator><creator>Rice, Kelly A</creator><creator>Roberts, Jeffery A</creator><creator>Russell-Logrigue, Kasi E</creator><creator>Salyards, Gregory W</creator><creator>Scorpio, Diana G</creator><creator>Weese, J Scott</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2286-1106</orcidid></search><sort><creationdate>20220901</creationdate><title>Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)</title><author>Bohm, Rudolf P ; Breed, Matthew W ; Cohen, Joyce K ; Haertel, Andrew J ; Halliday, Lisa C ; Kramer, Joshua A ; Lieberman, Mia T ; Rice, Kelly A ; Roberts, Jeffery A ; Russell-Logrigue, Kasi E ; Salyards, Gregory W ; Scorpio, Diana G ; Weese, J Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-7e31171422262cf8078b8117d0b89b201d88391aed67f2dcd7346e8f4044696d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Anti-infective agents</topic><topic>Antiinfectives and antibacterials</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Biology and Life Sciences</topic><topic>Campylobacter</topic><topic>Combined Modality Therapy</topic><topic>Complications and side effects</topic><topic>Dosage and administration</topic><topic>Drug resistance</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Formal Comment</topic><topic>Gastrointestinal diseases</topic><topic>Health care</topic><topic>Inflammation</topic><topic>Macaca mulatta</topic><topic>Medicine and Health Sciences</topic><topic>Mitigation</topic><topic>Pandemics</topic><topic>Pathogens</topic><topic>Public health</topic><topic>Reproducibility</topic><topic>Risk factors</topic><topic>Shigella</topic><topic>Simian Acquired Immunodeficiency Syndrome</topic><topic>Simian Immunodeficiency Virus</topic><topic>Staphylococcus infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bohm, Rudolf P</creatorcontrib><creatorcontrib>Breed, Matthew W</creatorcontrib><creatorcontrib>Cohen, Joyce K</creatorcontrib><creatorcontrib>Haertel, Andrew J</creatorcontrib><creatorcontrib>Halliday, Lisa C</creatorcontrib><creatorcontrib>Kramer, Joshua A</creatorcontrib><creatorcontrib>Lieberman, Mia T</creatorcontrib><creatorcontrib>Rice, Kelly A</creatorcontrib><creatorcontrib>Roberts, Jeffery A</creatorcontrib><creatorcontrib>Russell-Logrigue, Kasi E</creatorcontrib><creatorcontrib>Salyards, Gregory W</creatorcontrib><creatorcontrib>Scorpio, Diana G</creatorcontrib><creatorcontrib>Weese, J Scott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bohm, Rudolf P</au><au>Breed, Matthew W</au><au>Cohen, Joyce K</au><au>Haertel, Andrew J</au><au>Halliday, Lisa C</au><au>Kramer, Joshua A</au><au>Lieberman, Mia T</au><au>Rice, Kelly A</au><au>Roberts, Jeffery A</au><au>Russell-Logrigue, Kasi E</au><au>Salyards, Gregory W</au><au>Scorpio, Diana G</au><au>Weese, J Scott</au><au>Klatt, Nichole R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>18</volume><issue>9</issue><spage>e1010831</spage><epage>e1010831</epage><pages>e1010831-e1010831</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>[...]of these resistance patterns, the World Health Organization recently highlighted the need for new antimicrobials to treat fluoroquinolone-resistant Campylobacter and Shigella [6]. If AMR bacteria become more common in NHPs, potential spillover events may occur to humans leading to both serious public health consequences and erosion of public trust in our research endeavors. The authors did not monitor any bacterial resistance patterns before or after the treatment or report antimicrobial susceptibility of common bacteria identified within the colony. [...]if this approach is used, it must be reported in the literature in the methods section of papers to promote research reproducibility.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>36166449</pmid><doi>10.1371/journal.ppat.1010831</doi><tpages>e1010831</tpages><orcidid>https://orcid.org/0000-0002-2286-1106</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7374
ispartof PLoS pathogens, 2022-09, Vol.18 (9), p.e1010831-e1010831
issn 1553-7374
1553-7366
1553-7374
language eng
recordid cdi_plos_journals_2725275858
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Animals
Anti-infective agents
Antiinfectives and antibacterials
Antimicrobial agents
Bacteria
Biology and Life Sciences
Campylobacter
Combined Modality Therapy
Complications and side effects
Dosage and administration
Drug resistance
Drug resistance in microorganisms
Drug therapy
Formal Comment
Gastrointestinal diseases
Health care
Inflammation
Macaca mulatta
Medicine and Health Sciences
Mitigation
Pandemics
Pathogens
Public health
Reproducibility
Risk factors
Shigella
Simian Acquired Immunodeficiency Syndrome
Simian Immunodeficiency Virus
Staphylococcus infections
title Formal Comment on "Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques" by Bochart et al. (2021)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T01%3A05%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formal%20Comment%20on%20%22Mitigation%20of%20endemic%20GI-tract%20pathogen-mediated%20inflammation%20through%20development%20of%20multimodal%20treatment%20regimen%20and%20its%20impact%20on%20SIV%20acquisition%20in%20rhesus%20macaques%22%20by%20Bochart%20et%20al.%20(2021)&rft.jtitle=PLoS%20pathogens&rft.au=Bohm,%20Rudolf%20P&rft.date=2022-09-01&rft.volume=18&rft.issue=9&rft.spage=e1010831&rft.epage=e1010831&rft.pages=e1010831-e1010831&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1010831&rft_dat=%3Cgale_plos_%3EA720576072%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c610t-7e31171422262cf8078b8117d0b89b201d88391aed67f2dcd7346e8f4044696d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2725275858&rft_id=info:pmid/36166449&rft_galeid=A720576072&rfr_iscdi=true